NCT03758430
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- Joslin Diabetes Center Boston, Massachusetts, United States
Clinical trial condition
Diabetes Mellitus, Type 1
Explore clinical trials studying Diabetes Mellitus, Type 1. Study availability and eligibility vary by location and protocol.
881 public trials
62 recruiting studies
Diabetes Mellitus, Type 1 trial results
Completed
The Loop Observational Study
NCT03838900
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- Jaeb Center for Health Research Tampa, Florida, United States
NCT03643692
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- Imperial College Clinical Research Facility London, United Kingdom
NCT04161976
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- Profil Institut für Stoffwechselforschung Neuss, North Rhine-Westphalia, Germany
Completed
Patient Empowerment Through Predictive Personalised Decision Support(PEPPER)-Validation Study.
NCT03849755
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- Institut d'Investigació Biomèdica de Girona (IDIBGI) Girona, Spain
Completed
Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Tresiba®
NCT01984372
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
NCT02632747
- Conditions
- Autoimmune Diseases, Body Weight, Diabetes Mellitus, +13 more
- Locations
-
- Toronto General Hospital Toronto, Ontario, Canada
Completed
Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients
NCT04079413
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +8 more
- Locations
-
- Arkhangelsk Regional Clinical Hospital Arkhangelsk, Russia
- Kazan Endocrinology Dispensary Kazan', Russia
- Krasnoyarsk State Medical University named after Professor V.F. Voino-Yasenetsky Krasnoyarsk, Russia
- Endocrinology Research Centre (Moscow) Moscow, Russia
Completed
Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus
NCT02284009
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- GSK Investigational Site Bois-Guillaume, France
- GSK Investigational Site Caen, France
- GSK Investigational Site Lille, France
- GSK Investigational Site Munich, Bavaria, Germany
Completed
A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
NCT02703324
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Neuss, Germany